{"Title": "External validity of trials should be taken into account before asthma drug candidates reach market authorisation", "Year": 2016, "Source": "Lancet Respir. Med.", "Volume": "4", "Issue": 8, "Art.No": null, "PageStart": 601, "PageEnd": 603, "CitedBy": 2, "DOI": "10.1016/S2213-2600(16)30118-7", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84969940711&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Anti-Asthmatic Agents", "Asthma", "Drug Approval", "Female", "Humans", "Male", "Needs Assessment", "Patient Selection", "Product Surveillance, Postmarketing", "Randomized Controlled Trials as Topic", "United States"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-84969940711", "SubjectAreas": [["Pulmonary and Respiratory Medicine", "MEDI", "2740"]], "AuthorData": {"57189388690": {"Name": "Briasoulis O.", "AuthorID": "57189388690", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, University College London"}, "23495105200": {"Name": "Breckenridge R.", "AuthorID": "23495105200", "AffiliationID": "60022148", "AffiliationName": "Division of Medicine, University College London"}, "7102771386": {"Name": "Nunn A.", "AuthorID": "7102771386", "AffiliationID": "60022148, 60003108", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London"}}}